Small Molecule that Reverses Dexamethasone Resistance in T-cell Acute Lymphoblastic Leukemia (T-ALL)

被引：12
|
作者：
Cantley, Alexandra M. [1 ]
Welsch, Matthew [2 ]
Ambesi-Impiombato, Alberto [5 ]
Sanchez-Martin, Marta [5 ]
Kim, Mi-Yeon [5 ]
Bauer, Andras [1 ]
Ferrando, Adolfo [5 ,6 ,7 ]
Stockwell, Brent R. [1 ,2 ,3 ,4 ]
机构：
[1] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
[2] Columbia Univ, Dept Chem, New York, NY 10027 USA
[3] Columbia Univ, Howard Hughes Med Inst, New York, NY 10027 USA
[4] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA
[5] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA
[6] Columbia Univ, Dept Pathol, New York, NY 10032 USA
[7] Columbia Univ, Dept Pediat, New York, NY 10032 USA
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2014年 / 5卷 / 07期
基金：
美国国家卫生研究院;
关键词：
T-cell acute lymphoblastic leukemia; dexamethasone; glucocorticoid resistance; NOTCH1; GLUCOCORTICOID-INDUCED APOPTOSIS; GAMMA-SECRETASE INHIBITORS; SOLUBILITY; EXPRESSION; RECEPTOR; LINEAGE; NOTCH1; SET;
D O I：
10.1021/ml500044g
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Glucocorticoids are one of the most utilized and effective therapies in treating T-cell acute lymphoblastic leukemia. However, patients often develop resistance to glucocorticoids, rendering these therapies ineffective. We screened 9517 compounds, selected for their lead-like properties, chosen from among 3 372 615 compounds, against a dexamethasone-resistant T-ALL cell line to identify small molecules that reverse glucocorticoid resistance. We synthesized analogues of the most effective compound, termed J9, from the screen in order to define the scaffold's structure activity relationship. Active compounds restored sensitivity to glucocorticoids through upregulation of the glucocorticoid receptor. This compound and mechanism may provide a strategy for overcoming glucocorticoid resistance in patients with T-ALL.
引用
收藏
页码：754 / 759
页数：6
相关论文
共 50 条
  • [21] Upregulation of T-Cell-Specific Transcription Factor Expression in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL)
    Sayitoglu, Muge
    Erbilgin, Yucel
    Ng, Ozden Hatirnaz
    Yildiz, Inci
    Celkan, Tiraje
    Anak, Sema
    Devecioglu, Omer
    Aydogan, Gonul
    Karaman, Serap
    Sarper, Nazan
    Timur, Cetin
    Ure, Umit
    Ozbek, Ugur
    TURKISH JOURNAL OF HEMATOLOGY, 2012, 29 (04) : 325 - 333
  • [22] Outcomes Analysis of T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (T-ALL/T-LBL) in a Minority Rich Cohort
    Neupane, Karun
    Bazarbachi, Abdul-Hamid
    Reef, Daniel K.
    Pradhan, Kith
    Narvel, Hiba
    De Castro, Alyssa
    Joseph, Felisha
    Gillick, Kailyn
    Khatun, Fariha
    Lombardo, Amanda
    Shi, Yang
    Wang, Yanhua
    Gritsman, Kira
    Steidl, Ulrich
    Goldfinger, Mendel
    Kornblum, Noah
    Shastri, Aditi
    Mantzaris, Ioannis
    Rodriguez, Lizamarie Bachier
    Shah, Nishi
    Cooper, Dennis
    Braunschweig, Ira
    Verma, Amit
    Ye, Bin Hilda
    Konopleva, Marina
    Sica, R. Alejandro
    BLOOD, 2022, 140 : 11595 - 11597
  • [23] Modulation of Daratumumab efficacy by Decitabine in pediatric T-cell lymphoblastic leukemia (T-ALL)
    Autenrieb, M. P.
    Vogiatzi, F.
    Winterberg, D.
    Gelehrt, C. L.
    Lenk, L.
    Baumann, N.
    Wolf, S.
    Valerius, T.
    Peipp, M.
    Schewe, D. M.
    KLINISCHE PADIATRIE, 2022, 234 (03): : 184 - 185
  • [24] Transcriptional Regulation of Oncogenic MEF2C In T-Cell Acute Lymphoblastic Leukemia (T-ALL)
    Nagel, Stefan
    Venturini, Letizia
    Meyer, Corinna
    Kaufmann, Maren
    Scherr, Michaela
    Drexler, Hans G.
    MacLeod, Roderick A. F.
    BLOOD, 2010, 116 (21) : 1496 - 1496
  • [25] Methylation Status of Asparaginase Synthetase (ASNS) Gene in Childhood T-cell Acute Lymphoblastic Leukemia (T-ALL)
    Akahane, Koshi
    Kimura, Shunsuke
    Watanabe, Atsushi
    Shinohara, Tamao
    Harama, Daisuke
    Murakami, Yasushi
    Goi, Kumiko
    Kawai, Tomoko
    Hata, Kenichiro
    Kiyokawa, Nobutaka
    Koh, Katsuyoshi
    Imamura, Toshihiko
    Horibe, Keizo
    Sugita, Kanji
    Takita, Junko
    Inukai, Takeshi
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S16 - S16
  • [26] A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)
    Mavrakis, Konstantinos J.
    Van der Meulen, Joni
    Wolfe, Andrew L.
    Liu, Xiaoping
    Mets, Evelien
    Taghon, Tom
    Khan, Aly A.
    Setti, Manu
    Rondou, Pieter
    Vandenberghe, Peter
    Delabesse, Eric
    Benoit, Yves
    Socci, Nicholas B.
    Leslie, Christina S.
    Van Vlierberghe, Pieter
    Speleman, Frank
    Wendel, Hans-Guido
    NATURE GENETICS, 2011, 43 (07) : 673 - U89
  • [27] A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)
    Konstantinos J Mavrakis
    Joni Van Der Meulen
    Andrew L Wolfe
    Xiaoping Liu
    Evelien Mets
    Tom Taghon
    Aly A Khan
    Manu Setty
    Pieter Rondou
    Peter Vandenberghe
    Eric Delabesse
    Yves Benoit
    Nicholas B Socci
    Christina S Leslie
    Pieter Van Vlierberghe
    Frank Speleman
    Hans-Guido Wendel
    Nature Genetics, 2011, 43 : 673 - 678
  • [28] ECTOPIC EXPRESSION OF THE HEDGEHOG PATHWAY LIGANDS SHH AND IHH IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL)
    Dagklis, A.
    Pauwels, D.
    Lahortiga, I.
    Degryse, S.
    Jacobs, K.
    Mentens, N.
    Radaelli, E.
    Cools, J.
    HAEMATOLOGICA, 2014, 99 : 7 - 7
  • [29] Prognostic significance of clonal T-cell receptor (TCR) γ and δ gene rearrangements in Indian patients with T-cell acute lymphoblastic leukemia (T-ALL).
    Kode, JA
    Advani, SH
    Chiplunkar, SV
    FASEB JOURNAL, 2000, 14 (06): : A984 - A984
  • [30] Heterogeneity of T-acute lymphoblastic leukemia (T-ALL) cell lines: Suggestion for classification by immunophenotype and T-cell receptor studies
    Burger, R
    Hansen-Hagge, TE
    Drexler, HG
    Gramatzki, M
    LEUKEMIA RESEARCH, 1999, 23 (01) : 19 - 27
12345